Brainever
BrainEver is a biopharmaceutical company developing novel homeoprotein‑based therapies for neurodegenerative diseases such as ALS, Parkinson’s disease, age‑related macular degeneration and glaucoma. The company focuses on translating the homeoprotein concept into clinical pipelines, with multiple candidates in pre‑clinical and early clinical stages, and collaborates with academic and industry partners to advance treatments for patients suffering from these conditions.
Brainever is profiled on the APIs.io network. Tagged areas include Company, Biopharma, Neurodegenerative, Homeoprotein, and ALS.
Kin Score
Standards implemented 2
Standards this provider implements or carries. De facto ones are profiled and measured by the API Commons; formal ones come from the standards directory and are linked by the provider's own tags. The evidence column says how each claim was established — not that it was made.
Terms of Service 1
What its API terms permit and prohibit, quoted from its own page.
Privacy & Data 1
Its role, the data it processes, retention and transfers, quoted from its own privacy page.
Eligibility 1
Who may sign up and where, quoted from its own terms.
Data License 1
How its data and outputs may be reused, quoted from its own terms.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Commercial 4
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API
Other 3
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.